Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of neural transmission

• Publication date

  2008-09-20

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00702-008-0122-8PMID 18806925
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia

  2008cited by this paper
• Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia.

  2008cited by this paper
• Towards a muscarinic hypothesis of schizophrenia

  2007cited by this paper
• Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.

  2007cited by this paper
• Scopolamine Induces Disruption of Latent Inhibition which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor

  2007cited by this paper
• Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain.

  2006cited by this paper
• Overexpression of glucose-regulated protein 78 in colon cancer.

  2006cited by this paper
• Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

  2005cited by this paper
• A putative animal model of the "prodromal" state of schizophrenia.

  2005cited by this paper
• Pharmacologic Interactions between the Muscarinic Cholinergic and Dopaminergic Systems in the Modulation of Prepulse Inhibition in Rats

  2005cited by this paper
• 5-HT2A and muscarinic receptors in schizophrenia: a postmortem study.

  2005cited by this paper
• N-Desmethylclozapine, a Major Metabolite of Clozapine, Increases Cortical Acetylcholine and Dopamine Release In Vivo Via Stimulation of M1 Muscarinic Receptors

  2005cited by this paper
• Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

  2005cited by this paper
• Investigation of M1/M4 Muscarinic Receptors in the Anterior Cingulate Cortex in Schizophrenia, Bipolar Disorder, and Major Depression Disorder

  2004cited by this paper
• M1 Receptor Agonism, a Possible Treatment for Cognitive Deficits in Schizophrenia

  2004cited by this paper
• Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia.

  2003cited by this paper
• Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion

  2003cited by this paper
• The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

  2003cited by this paper
• Central Muscarinic Acetylcholine Receptor Availability in Patients Treated with Clozapine

  2003cited by this paper
• In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia.

  2003cited by this paper
• Muscarinic receptors as a target for drugs treating schizophrenia.

  2002cited by this paper
• Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

  2002cited by this paper
• Antibodies Against Cerebral M1 Cholinergic Muscarinic Receptor from Schizophrenic Patients: Molecular Interaction1

  2002cited by this paper
• Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.

  2002cited by this paper
• Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

  2002cited by this paper
• Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice

  2001cited by this paper
• Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine.

  2001cited by this paper
• Searching for schizophrenia genes.

  2001cited by this paper
• Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.

  2001cited by this paper
• Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

  2000cited by this paper
• Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia

  2000cited by this paper
• In Vivo Olanzapine Occupancy of Muscarinic Acetylcholine Receptors in Patients with Schizophrenia

  2000cited by this paper
• The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia.

  1999cited by this paper
• Potential role of muscarinic receptors in schizophrenia.

  1999cited by this paper
• Dopaminergic and cholinergic interaction in cataleptic responses in mice.

  1997cited by this paper
• Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease

  1995cited by this paper
• Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry

  1994cited by this paper
• Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

  1991cited by this paper
• Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia.

  1989cited by this paper
• Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.

  1988cited by this paper
• Neurotransmitters, receptors and neuropeptides in post‐mortem brains of chronic schizophrenic patients

  1988cited by this paper
• Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

  1986cited by this paper
• [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.

  1986cited by this paper
• Goodman and Gilman's the Pharmacological Basis of Therapeutics

  1986cited by this paper
• [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.

  1986cited by this paper
• Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics.

  1983cited by this paper
• [3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex.

  1982cited by this paper
• Physostigmine and lithium response in the schizophrenias.

  1981cited by this paper
• Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects.

  1980cited by this paper
• Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.

  1977cited by this paper
• Effects of chronic d-amphetamine on social behavior of the rat: Implications for an animal model of paranoid schizophrenia

  1976cited by this paper
• Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.

  1974cited by this paper

• Distinct Effects of Olanzapine Depot Treatment on Behavior and Muscarinic M1 Receptor Expression in the Triple‐Hit Wisket Rat Model of Schizophrenia

  2025cites this paper
• Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia

  2023cites this paper
• Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia.

  2022cites this paper
• Auditory mismatch responses are differentially sensitive to changes in muscarinic acetylcholine versus dopamine receptor function

  2021cites this paper
• Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage.

  2014cites this paper
• Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain: impact of antipsychotic drug treatment.

  2012cites this paper
• Embryonic Amygdalar Transplants in Adult Rats with Motor Cortex Lesions: A Molecular and Electrophysiological Analysis

  2011cites this paper
• Animal Models of Schizophrenia

  2009cites this paper
• Auditory mismatch responses are differentially sensitive to 1 changes in muscarinic acetylcholine versus dopamine 2 receptor function

  year unknowncites this paper